What one share of Armata Pharmaceuticals holds
We are a late clinical-stage biotechnology company focused on the development of high-purity and potency, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using our proprietary bacteriophage-based technology.
Armata Pharmaceuticals’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Profit | −$5.27 |
|---|---|
| Capex (buildings and equipment) | $0.01 |
| Free cash flow | −$0.71 |
| Cash and investments | $0.64 |
| Book value | −$6.22 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2013 | — | −$322.13 | $0.50 | −$31.59 | — | −$61.97 |
| 2014 | — | −$23.30 | $2.04 | −$23.40 | — | $8.63 |
| 2015 | — | −$19.95 | $0.39 | −$18.46 | — | $21.61 |
| 2016 | — | −$24.67 | $0.28 | −$11.06 | — | $5.90 |
| 2017 | — | −$2.18 | $0.01 | −$1.41 | — | $2.56 |
| 2018 | — | −$3.59 | $0.19 | −$2.47 | — | $1.52 |
| 2019 | — | −$2.55 | $0.03 | −$1.97 | — | $1.47 |
| 2020 | — | −$1.35 | $0.05 | −$1.16 | — | $1.01 |
| 2021 | — | −$0.96 | $0.05 | −$1.03 | — | $0.94 |
| 2022 | — | −$1.08 | $0.06 | −$1.01 | — | $1.00 |
| 2023 | — | −$1.91 | $0.23 | −$1.54 | — | −$0.89 |
| 2024 | — | −$0.89 | $0.03 | −$0.67 | — | −$1.33 |
| 2025 | — | −$4.80 | $0.01 | −$0.73 | — | −$6.00 |
Common questions about Armata Pharmaceuticals
How much does one share of Armata Pharmaceuticals earn?
Over the last 12 months, Armata Pharmaceuticals lost $5.27 for each share.
Does Armata Pharmaceuticals pay a dividend?
Armata Pharmaceuticals didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Armata Pharmaceuticals’s book value per share?
Armata Pharmaceuticals’s book value is negative (−$6.22 per share): it owes more than everything it owns is recorded at, often after years of buying back its own shares, as of June 30, 2026.
How much cash and debt does each share of Armata Pharmaceuticals have?
Each share of Armata Pharmaceuticals has $0.64 of cash and investments, as of June 30, 2026.
What is Armata Pharmaceuticals’s free cash flow per share?
−$0.71 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has Armata Pharmaceuticals bought back shares?
Armata Pharmaceuticals’s share count rose about 17804% from 2013 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.